BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Abliva - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://abliva.com
X-WR-CALDESC:Events for Abliva
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240318
DTEND;VALUE=DATE:20240321
DTSTAMP:20260613T213723
CREATED:20240122T100207Z
LAST-MODIFIED:20240318T085921Z
UID:4130-1710720000-1710979199@abliva.com
SUMMARY:Mitochondrial Medicine - Therapeutic Development
DESCRIPTION:In mid-March\, Abliva will attend the 8th edition of Mitochondrial Medicine – Therapeutic Development in Hinxton\, UK. \nThis annual scientific meeting is focused on mitochondrial disorders and the search for novel effective therapies. \nAbliva’s CMO\, Maguns Hansson\, will join the panel discussion Challenges and opportunities in clinical trials: perspectives\nfrom pharma and funders\, where representatives from other companies in the field as well as academic and clinical experts also participate. \nFollow the link below to learn more.
URL:https://abliva.com/event/mitochondrial-medicine-therapeutic-development-5/
LOCATION:MA
CATEGORIES:Scientific event
ATTACH;FMTTYPE=image/jpeg:https://abliva.com/wp-content/uploads/2024/01/Magnus_Fia_kameraa-e1710752165285.jpg
END:VEVENT
END:VCALENDAR